Metallothionein: A multifunctional protein from toxicity to cancer

International Journal of Biological Markers

Volumn 18, Issue 3, 2003, Pages 162-169

  Theocharis, Stamatios E ^a   Margeli, A P ^b   Koutselinis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Apoptosis; Cancer; Cell proliferation; Drug resistance; Metallothionein

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYSTEINE; DOXORUBICIN; FLUOROURACIL; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; MELPHALAN; METAL ION; METALLOTHIONEIN; METALLOTHIONEIN 4; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; MITOMYCIN C; NITRIC OXIDE; PEPLEOMYCIN; UNCLASSIFIED DRUG; VINBLASTINE;

APOPTOSIS; BINDING AFFINITY; CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CARCINOGENICITY; CELL PROLIFERATION; CELL PROTECTION; DEFENSE MECHANISM; DETOXIFICATION; DRUG EFFICACY; HOMEOSTASIS; HUMAN; INJURY; INTRACELLULAR FLUID; ISOMERISM; MAMMAL; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; STRESS; THERAPY RESISTANCE; TUMOR DIFFERENTIATION;

MAMMALIA;

EID: 0141920774     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.196     Document Type: Review

References (65)

1. Margoshes M, Valle BC. A cadmium binding protein for equine kidney cortex. J Am Chem Soc 1957; 79: 4813-4.
2. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 aminoacid metallothionein-like protein. Neuron 1991; 7: 337-47.
3. Imagawa M, Ishikawa Y, Shimano H, Osada S, Nishihara T. CTG triplet repeat in mouse growth inhibitory factor/metallothionein III gene promoter represses the transcriptional activity of the heterologous promoters. J Biol Chem 1995; 270: 20898-900.
4. Palmiter RD, Findley SD, Whitmore TE, Durnam DM. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 1992; 89: 6333-7.
5. Quaife CI, Findley SD, Erickson JC, et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33: 7250-9.
6. Vasak M, Overnell J, Good M. Spectroscopic and chemical approaches to the study of metal-thiolate clusters in metallothionein (MT). Experientia Suppl 1987; 52: 179-89.
7. Moffatt P, Seguin C. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol 1998; 17: 501-10.
8. Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 1995; 34: 4740-7.
9. Kojima Y. Definitions and nomenclature of metallothionein. Methods Enzymol 1991; 205: 8-10.
10. Moffatt P, Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab Rev 1997; 29: 261-307.
11. Jiang LJ, Maret W, Vallee BL. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proc Natl Acad Sci USA 1998; 95: 3483-8.
12. Pattanaik A, Shaw CF 3rd, Petering DH, Garvey J, Kraker AJ. Basal metallothionein in tumors: Widespread presence of apoprotein. J Inorg Biochem 1994; 54: 91-105.
13. Ogra Y, Suzuki KT. Biological significance of non-acetylated metallothionein. Chromatogr B Biomed Sci Appl 1999; 735: 17-24.
14. Zeng J, Vallee BL, Kagi JHR. Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc Natl Acad Sci USA 1991; 88: 9984-8.
15. Zeng J, Heuchel R, Schaffner W, Kagi JHR. Thionein (apoprotein) can modulate DNA binding and transcription activation by zinc finger containing factor SP1. FEBS Lett 1991; 279: 310-2.
16. Maret W, Jacob C, Vallee BL, Fischer EH. Inhibitory sites in enzymes: Zinc removal and reactivation by thionein. Proc Natl Acad Sci USA 1999; 96: 1936-40.
17. Cherian MG, Huang PC, Klaassen CD, Lin Y-P, Lonfgellow DG, Waalkes MP. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 1993; 53: 922-5.
18. St Croix CM, Wasserloos KJ, Dineley KE, Reynolds IJ, Levitan ES, Pitt BR. Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. Am J Physiol Lung Cell Mol Physiol 2002; 282: L185-92.
19. Fabisiak JP, Borisenko GG, Liu SX, Tyurin VA, Pitt BR, Kagan VE. Redox sensor function of metallothioneins. Methods Enzymol 2002; 353: 268-81.
20. Jacob C, Maret W, Vallee BL. Selenium redox biochemistry of zinc-sulfur coordination sites in proteins and enzymes. Proc Natl Acad Sci USA 1999; 96: 1910-4.
21. Jimenez I, Aracena P, Letelier ME, Navarro P, Speisky H. Chronic exposure of HepG2 cells to excess copper results in depletion of glutathione and induction of metallothionein. Toxicol in Vitro 2002; 16: 167-75.
22. Kelly EJ, Palmiter RD. A murine model of Menkes disease reveals a physiological function of metallothionein. Nat Genet 1996; 13: 219-22.
23. Zangger K, Oz G, Haslinger E, Kunert O, Armitage IM. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: Potential role at inflammatory sites. FASEB J 2001; 15: 1303-5.
24. Rostan EF, DeBuys HV, Madey DL, Pinnell SR. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol 2002; 41: 606-11.
25. Schwarz MA, Lazo JS, Yalowich JC, et al. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 1995; 92: 4452-6.
26. Tamai KT, Gralla EB, Ellerby LM, Valentine JS, Thiele DJ. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc Natl Acad Sci USA; 1993; 90: 8013-7.
27. Lazo JS, Kondo Y, Dellapiazza D, Michalska AE, Choo KH, Pitt BR. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes. J Biol Chem 1995; 270: 5506-10.
28. Pitt BR, Schwarz M, Woo ES, et al. Overexpression of metallothionein decreases sensitivity of pulmonary endothelial cells to oxidant injury. Am J Physiol 1997; 273: L856-65.
29. Schwarz MA, Lazo JS, Yalowich JC, et al. Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J Biol Chem 1994; 269: 15238-43.
30. Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PN. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 1997; 100: 1501-6.
31. Lazo JS, Kuo SM, Woo ES, Pitt BR. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem Biol Interact 1998; 111-112: 255-62.
32. Zhong W, Zhang Q, Yan Y, Yue S, Zhang B, Tang W. Reaction of a platinum (IV) complex with native Cd,Zn-metallothionein in vitro. J Inorg Biochem 1997; 66: 179-85.
33. Zhong W, Zhang Q, Yan Y, Yue S, Zhang B, Tang W. Interaction of sodium chloroplatinate and iproplatin with metallothionein in vivo. J Inorg Biochem 1997; 66: 159-64.
34. Kondoh M, Inoue Y, Atagi S, Futakawa N, Higashimoto M, Sato M. Specific induction of metallothionein synthesis by mitochondrial oxidative stress. Life Sci 2001; 69: 2137-46.
35. Jasani B, Schmid KW. Significance of metallothionein overexpression in human tumours. Histopathology 1997; 31: 211-4.
36. Suganuma K, Kubota T, Saikawa Y, et al. Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray. Cancer Sci 2003; 94: 355-9.
37. Hartwig A, Asmuss M, Blessing H, et al. Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic stability. Food Chem Toxicol 2002; 40: 1179-84.
38. Hartwig A, Asmuss M, Ehleben I, et al. Interference by toxic metal ions with DNA repair processes and cell cycle control: Molecular mechanisms. Environ Health Perspect 2002; 110: 797-9.
39. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994; 265: 346-55.
40. Coffer AI, Knowles PP. Divalent metal ions induce configurational change in pure, human wild-type p53 tumor suppressor gene. Biochim Biophys Acta 1994; 1209: 279-85.
41. Hainaut P, Milner JA. A structural role of metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res 1993; 53: 1739-42.
42. Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 1993; 7: 2556-64.
43. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995; 15: 3892-903.
44. Meplan C, Richard MJ, Hainaut P. Metalloregulation of the tumor suppressor protein p53: Zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 2000; 19: 5227-36.
45. Abdel-Mageed A, Agrawal KC. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Therapy 1997; 4: 199-207.
46. Majumder S, Ghoshal K, Li Z, Jacob ST. Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation. Oncogene 1999; 18: 6287-95.
47. Majumder S, Ghoshal K, Datta J, et al. Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. J Biol Chem 2002; 277: 16048-58.
48. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, Lazo JS. Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 1997; 52: 195-201.
49. Cherian G, Howell SB, Imura N, et al. Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol 1994; 126: 1-5.
50. Levadoux-Martin M, Hesketh JE, Beattie JH, Wallace HM. Influence of metallothionein-1 localization on its function. Biochem J 2001; 355: 473-9.
51. Wang GW, Zhou Z, Klein JB, Kang YJ. Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am J Physiol Heart Circ Physiol 2001; 280: H2292-9.
52. Apostolova MD, Ivanova IA, Cherian MG. Metallothionein and apoptosis during differentiation of myoblasts to myotubes: Protection against free radical toxicity. Toxicol Appl Pharmacol 1999; 159: 175-84.
53. Tsangaris GT, Tzortzatou-Stathopoulou F. Metallothionein expression prevents apoptosis: A study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. Anticancer Res 1998; 18: 2423-33.
54. Tekur S, Ho SM. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines. Mol Carcinog 2002; 33: 44-55.
55. Yu X, Wu Z, Fenselau C. Covalent sequestration of melphalan by metallothionein and selective alkylation of cysteines. Biochemistry 1995; 34: 3377-85.
56. He T, Wei D, Fabris D, Fenselau C. Intracellular sequestration of anti-tumor drugs by metallothionein. Cell Mol Biol 2000; 46: 383-92.
57. Akiyama S, Chen ZS, Sumizawa T, Furukawa T. Resistance to cisplatin. Anticancer Drug Res 1999; 14: 143-51.
58. Okazaki Y, Miura N, Satoh M, Imura N, Naganuma A. Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice. Biochem Biophys Res Commun 1998; 245: 815-8.
59. Vandier D, Calvez V, Massade L, et al. Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: A specific gene therapy strategy. J Natl Cancer Inst 2000; 92: 642-7.
60. Shimoda R, Achanzar WE, Qu W, et al. Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci 2003; 73: 294-300.
61. Cai L, Satoh M, Tohyama C, Cherian MG. Metallothionein in radiation exposure: Its induction and protective role. Toxicology 1999; 132: 85-98.
62. Ota T, Hanada K, Hashimoto I. The effect of cold stress on UVB injury in mouse skin and cultured keratinocytes. Photochem Photobiol 1996; 64: 984-7.
63. Hanada K. Photoprotective role of metallothionein in UV-injury-metallothionein-null mouse exhibits reduced tolerance against ultraviolet-B. J Dermatol Sci 2000; 23 (Suppl 1): S51-S56.
64. Hanada K, Sawamura D, Tamai K, et al. Novel function of metallothionein in photoprotection: Metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skin. J Invest Dermatol 1998; 111: 582-5.
65. Shibuya K, Satoh M, Muraoka M, Watanabe Y, Oida M, Shimizu H. Induction of metallothionein synthesis in transplanted murine tumors by X irradiation. Radiat Res 1995; 143: 54-7.